Abstract
This editorial explores Burris's examination, in this issue, of combined modality anticancer treatment and radiation recall.
MeSH terms
-
Antineoplastic Agents / adverse effects*
-
Antineoplastic Agents / therapeutic use
-
Breast Neoplasms / drug therapy
-
Breast Neoplasms / radiotherapy
-
Combined Modality Therapy
-
Epothilones / adverse effects
-
Epothilones / therapeutic use
-
Female
-
Humans
-
Neoplasms / drug therapy*
-
Neoplasms / radiotherapy*
-
Radiodermatitis*
-
Radiotherapy / adverse effects
Substances
-
Antineoplastic Agents
-
Epothilones
-
ixabepilone